The Color of Itch; Itch Modification by Color Viewing

Pruritus Clinical Trial

Official title:

The Color of Itch; Itch Modification by Color Viewing- an Exploratory Survey

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03928223
• Other study ID #: Req 2017-1; sp19Mueller4
• Status: Completed
• Start date: March 1, 2017
• Est. completion date: August 31, 2018

Study information

• Verified date: April 2019
• Source: University Hospital, Basel, Switzerland
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Itch is the commonest skin-related symptom. There is increasing evidence that itch can be influenced by visual cues. The impact of colors on itch has not yet been studied.

This study investigates Itch modification by color viewing and whether patients can match or counteract their itch with a color.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 72
• Est. completion date: August 31, 2018
• Est. primary completion date: August 31, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 16 Years and older

Eligibility

Inclusion Criteria:

• Dermatology in- and outpatients with itch

Exclusion Criteria:

• color blindness

• lack of time

• lack of German language.

Related Conditions & MeSH terms

• Itch
• Pruritus

Intervention

Other:
• exploratory survey on Itch modification by color viewing
Patients relate their itch to a color of the Manchester Color Wheel (MCW) and choose a color of the MCW aimed at counteracting their itch. They complete the ItchyQoL (German version), which is a standard tool to assess itch-related quality of life. Then patients look at their "antipruritic" monochrome color for five minutes on a lap-top screen. Itch intensity (0-10 NRS) will be assessed at baseline and again after the patients looked at this color for 5 minutes.

Locations

Country	Name	City	State
Switzerland	Department of Dermatology, University Hospital Basel	Basel

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Basel, Switzerland

Country where clinical trial is conducted

Switzerland, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in itch intensity	Change in itch intensity (measured on a 0-10 Numerical Rating Scale, NRS); 0 = no itch; 10 = most intensive itch	assessed at baseline and again after the patients looked at the "antipruritic" color for 5 minutes